- Bestsellers
- Alcoholism
- COVID-19
- Allergy
- Anti Fungal
- Alzheimers
- Anti Viral
- Anti-Depressants
- Anti-Inflammatory
- Antibacterial
- Antiparasitic
- Antibiotics
- Arthritis
- Asthma
- Birth Control
- Blood Pressure
- Cancer
- Cardiovascular
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Drop
- Gastro Health
- General Health
- Hair Loss
- Hepatitis C Virus (HCV)
- HIV
- Hormones
- Men's ED Packs
- Men's Health
- Mental Illness
- Motion Sickness
- Muscle Relaxant
- Pain Relief
- Parkinson’s Disease
- Veterinary Medicines
- Quit Smoking
- Vitamins
- Skin Care
- Sleeping Aids
- Weight Loss
- Women's Health
Generic Stromectol ( Ivermectin )
Stromectol (ivermectin) is an anthelmintic and antiparasitic agent indicated for the treatment of strongyloidiasis (intestinal infection caused by Strongyloides stercoralis) and onchocerciasis (river blindness caused by Onchocerca volvulus). It belongs to the avermectin class of antiparasitic compounds and works by selectively binding with high affinity to glutamate-gated chloride ion channels present in invertebrate nerve and muscle cells. This binding increases the permeability of the cell membrane to chloride ions, leading to hyperpolarization of the nerve or muscle cell, paralysis, and eventual death of the parasite. In addition, ivermectin interferes with other ligand-gated ion channels unique to invertebrates, contributing to its broad-spectrum antiparasitic activity. It has minimal affinity for mammalian ligand-gated chloride channels, which accounts for its favorable safety profile in humans. Stromectol does not cross the blood-brain barrier to a significant extent in most individuals, as it is actively effluxed by the P-glycoprotein transporter.
Usual adult dose: For strongyloidiasis, the recommended dose is a single oral dose of approximately 200 mcg per kilogram of body weight, typically administered as 2 tablets of 3 mg each for a total single dose of 6 mg in most adults, followed by water on an empty stomach at least 1 hour before or 2 hours after a meal. For onchocerciasis, the recommended dose is a single oral dose of approximately 150 mcg per kilogram of body weight, usually administered as 2 tablets of 3 mg each for a total single dose of 6 mg in most adults, taken on an empty stomach with water. In the treatment of onchocerciasis, additional doses at intervals of 3 to 12 months may be necessary to suppress microfilariae, as ivermectin is microfilaricidal but does not kill the adult worms. Patients with heavy ocular infection may require concomitant corticosteroid therapy to control inflammatory reactions to the death of microfilariae. Dosing should be based on precise body weight, particularly in patients under 65 kg or over 85 kg, where adjusted doses of 3 mg or 12 mg may be required.
Dosage form: Tablets: 3 mg (white, round, flat, bevelled-edge, scored). The scored tablet design allows for accurate weight-based dosing. Each tablet contains 3 mg of ivermectin with inactive excipients. The tablet may be split at the score line to accommodate individualized weight-adjusted regimens.
Onset of action: Following oral administration, ivermectin is absorbed from the gastrointestinal tract, with peak plasma concentrations achieved approximately 4 hours after dosing. In the treatment of strongyloidiasis, reduction in larval output begins promptly, with clearance of larvae from the stool typically achieved within 1 to 2 days. In onchocerciasis, the microfilaricidal effect in the skin is rapid, with a significant reduction in dermal microfilariae observed within 2 to 3 days; suppression of ocular microfilariae follows a similar time course and persists for approximately 6 to 12 months after a single dose.
Duration of action: The elimination half-life of ivermectin is approximately 18 hours, with the drug and its metabolites excreted almost exclusively in the feces over an estimated 12 days. Despite the relatively short plasma half-life, the antiparasitic effect against microfilariae is sustained for 6 to 12 months, particularly in onchocerciasis, reflecting the drug's high protein binding and its concentration within parasitic tissues. In strongyloidiasis, a single dose is often curative, with efficacy evaluated by repeat stool examinations.
Alcohol recommendation: No specific clinically significant interaction between ivermectin and alcohol has been established. Alcohol consumption does not directly alter the antiparasitic efficacy or pharmacokinetics of ivermectin in a clinically meaningful way. However, alcohol intake may increase the risk of gastrointestinal upset, dizziness, and central nervous system side effects such as drowsiness, which are already potential adverse effects of ivermectin. Patients are advised to exercise moderation and to understand how the combination affects them, particularly before driving or undertaking activities requiring mental alertness. Abstinence from alcohol for at least 24 hours after treatment is a prudent precaution.
Most common side effects: In the treatment of strongyloidiasis, adverse effects are generally mild and include gastrointestinal symptoms such as diarrhea, nausea, and abdominal discomfort, as well as fatigue, dizziness, and pruritus. In the treatment of onchocerciasis, adverse effects are predominantly due to the allergic and inflammatory response to the rapid death of microfilariae (Mazzotti reaction) rather than to the drug itself. These reactions include fever, pruritus, urticaria, myalgia, arthralgia, lymphadenopathy, edema, and postural hypotension. In patients with heavy Onchocerca volvulus infection, more severe reactions may occur, including ophthalmologic inflammatory events. Concomitant administration of antihistamines or corticosteroids may be necessary to mitigate these inflammatory reactions. Rare but serious neurological adverse effects, including confusion, stupor, and coma, have been reported, particularly in patients with heavy Loa loa co-infection, where high microfilarial loads can trigger severe encephalopathy. Ivermectin is contraindicated in patients with known hypersensitivity to any component of the formulation and should be used with caution in populations where Loa loa is endemic without appropriate pretreatment screening.
Would you like to learn more about Stromectol (Ivermectin) for the treatment of parasitic infections?
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
